Other Income/Expenses (Net)

$402.90M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$402.90Mperiod endingJun 30, 2026

VRTX TTM Other Income/Expenses (Net) ($4.10M → $402.90M)

TTM Other Income/Expenses (Net)

High-resolution chart · PNG

VRTX other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2001	-9,608,000
Mar 31, 2001	-14,944,000
Dec 31, 2000	-15,565,000
Sep 30, 2000	-15,508,000
Jun 30, 2000	1,584,000
Mar 31, 2000	4,057,000
Dec 31, 1999	7,778,000
Sep 30, 1999	7,878,000
Jun 30, 1999	5,578,000
Mar 31, 1999	3,100,000
Dec 31, 1998	4,000,000
Sep 30, 1998	4,000,000
Jun 30, 1998	4,000,000
Mar 31, 1998	4,000,000
Dec 31, 1997	0
Sep 30, 1997	1,800,000
Jun 30, 1997	3,000,000
Mar 31, 1997	-11,000,000
Dec 31, 1996	-9,700,000
Sep 30, 1996	-9,900,000
Jun 30, 1996	-9,900,000
Mar 31, 1996	5,500,000
Dec 31, 1995	5,500,000
Sep 30, 1995	3,900,000
Jun 30, 1995	2,700,000
Mar 31, 1995	1,300,000
Dec 31, 1994	0
Sep 30, 1994	400,000
Jun 30, 1994	700,000
Mar 31, 1994	1,100,000
Dec 31, 1993	1,400,000
Sep 30, 1993	1,400,000
Jun 30, 1993	1,600,000
Mar 31, 1993	1,700,000
Dec 31, 1992	2,000,000
Sep 30, 1992	2,000,000
Jun 30, 1992	1,800,000
Mar 31, 1992	1,400,000
Dec 31, 1991	0
Sep 30, 1991	5,400,000
Jun 30, 1991	4,500,000
Mar 31, 1991	3,800,000
Dec 31, 1990	4,100,000